Wells Fargo’s Ocugen OCGN Stock Holding History

Wells Fargo’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,500	Closed	-$46K	–	7350
2021 Q2	$46K	Buy	+4,500	New	+$38K	﹤0.01%	5590

Other funds holding OCGN

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Wells Fargo's OCGN Position: Q1 2026 in Review

Wells Fargo increased its Ocugen (OCGN) stake by 1,847% in Q1 2026, buying an estimated $128K and bringing the position to 77,901 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #4913.

Wells Fargo first reported a position in OCGN in Q1 2017 and has held it in 28 quarters since. The position peaked at $1.15M in Q3 2021. 137 funds tracked by Wall St. Rank hold OCGN as of Q1 2026.

Wells Fargo held 77,901 shares of Ocugen worth $141K as of Q1 2026.
Wells Fargo bought 73,900 Ocugen shares in Q1 2026, an estimated $128K.
Ocugen made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4913 holding.
Wells Fargo first reported a position in Ocugen in Q1 2017 and has held it in 28 quarters since.
Wells Fargo's Ocugen position peaked at $1.15M in Q3 2021.
137 funds tracked by Wall St. Rank held Ocugen as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.